Companies: 10,795·Total market cap: $144.5T
Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPNNASDAQHealthcare
$64.97
+$0.01(+0.02%)
Market Cap$4.5B
P/E Ratio
52W High$65.0
52W Low$8.33
Overview

Alpine Immune Sciences, Inc. (ALPN) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · ALPN · as of Jun 8, 2026

Key Statistics

EPS (TTM)$-0.69alpn eps ttm · alpn earnings per shareEarnings history
PE Ratio (TTM)alpn pe ratio ttm · alpn price to earningsPE Ratio deep dive
Revenue (TTM)$56.5Malpn revenue ttm · alpn annual revenueFull revenue history
Dividend YieldNo Dividenddoes alpn pay dividends · alpn dividend yieldDividend history
Shares Outstanding50.0Malpn shares outstanding · alpn floatShares outstanding history
Next EarningsTBAalpn earnings date · alpn next earningsEarnings history

Financial Snapshot

Full Financials
FY 2023Revenue$58.9M▲ +95.84% YoY
202120222023
alpine immune sciences, inc. revenue · alpn revenue 2023
FY 2023Net Income-$32.2M▲ +44.28% YoY
202120222023
alpine immune sciences, inc. net income · alpn profit 2023
FY 2023EPS$-0.64▲ +63.01% YoY
202120222023
alpn eps · alpine immune sciences, inc. earnings per share 2023
TTM:Revenue: $56.5MNet Income: -$36.8MEPS: $-0.69View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy15 analystsis alpn a buy · alpn analyst rating
Strong Buy
0
Buy
9
Hold
6
Sell
0
Strong Sell
0
12-Month Price Target
$44.00Low
$64.97Current
$55.00Avg Target15.35% downside
$65.00High
alpn price target · alpn 12 month forecast

Total: 15 · Buy rate: 60.0%

The ALPN analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $55.00, representing -15.35% downside from the current price of $64.97.

Stock Performance

Full History
1D+0.00%
1W+0.00%
1M+0.02%
3M+78.59%
YTD+241.95%
1Y+475.98%
5Y+1343.78%

About Alpine Immune Sciences, Inc.

CEOMitchell H. Gold
IPO DateJun 17, 2015
Employees142
CountryUS

Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions…

what is alpine immune sciences, inc. · alpn stock overview · alpine immune sciences, inc. company profile · who is alpine immune sciences, inc. ceo · alpn NASDAQ · alpine immune sciences, inc. headquarters · alpine immune sciences, inc. business segments

About Stock Overview & Key Data

Alpine Immune Sciences, Inc. (ALPN) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 17, 2015. As of the latest trading session, ALPN stock price is $64.97, with a market capitalization of $4.5B. The stock has returned +475.98% over the past 12 months and +241.95% year-to-date.

According to 15 Wall Street analysts, the consensus rating for Alpine Immune Sciences, Inc. stock is Buy, with an average 12-month price target of $55.00. In fiscal year 2023, Alpine Immune Sciences, Inc. reported revenue of $58.9M and net income of -$32.2M. For detailed data — including Alpine Immune Sciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Alpine Immune Sciences, Inc. (ALPN) stock price is $64.97. The stock is traded on NASDAQ under the ticker symbol ALPN. The 52-week range is $8.33 – $65.00.

ALPN stock priceALPN quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice